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http://dx.doi.org/10.1016/j.pedneo.2
1875-9572/Copyright ª 2014, Taiwan P
NC-ND license (http://creativecommoEwing’s sarcoma (EWS) and peripheral primitive neuroectodermal tumor (pPNET) are small
round cell malignancies that develop in soft tissue and bone. They very rarely affect newborns.
A diagnosis of EWS/pPNET depends mainly on immunohistochemistry and molecular/genetic
assays. Since these tumors are highly aggressive, patient prognosis is typically very poor,
and treatment remains a challenge. Here, we report a 13-day-old newborn diagnosed with
congenital EWS/pPNET and describe its treatment.
Copyright ª 2014, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).1. Introduction
Ewing’s sarcoma (EWS) and peripheral primitive neuro-
ectodermal tumor (pPNET) are two types of malignant
tumor that are histologically characterized by the presence
of small, round cells in soft tissues and bone.1 This rare
malignancy occurs primarily in children and adolescents,
but it is extremely rare in newborns. Here, we describe a
13-day-old newborn diagnosed with EWS/pPNET in her
upper left arm.t of Pediatric Surgery, West
Chengdu 610041, China.
.com (S.-G. Jin).
013.11.002
ediatric Association. Published by
ns.org/licenses/by-nc-nd/4.0/).2. Case report
A 13-day-old newborn female was admitted due to a
swollen mass on her upper-left arm after birth. She was a
full-term cesarean neonate without a family history of ge-
netic diseases. A physical examination revealed a round,
soft, dark mass with clear boundaries, measuring about
5 cm  5 cm  4 cm, in her upper left arm. There was no
increase in local skin temperature or any detectable fluc-
tuation. An ultrasound showed a well-defined isoechoic
mass close to the brachial artery with point-like blood flow
within the mass, and rich blood flow surrounding the mass.
Computed tomography (CT) detected an isodense soft tis-
sue mass measuring 4.6 cm  3.7 cm in the coronal
maximum of her upper left arm, which was attached to the
biceps and triceps (Figure 1). Enhanced scanning further
showed a heterogeneously enhanced mass pressing onto theElsevier Taiwan LLC. This is an open access article under the CC BY-
Figure 1 Computed tomography detects a mass present in
the upper left arm.
Congenital EWS/pPNET 437left brachial artery, with branches of the brachial artery
extending within the mass. The bone in the left humerus
did not appear to be affected.
The mass was completely resected and, upon gross in-
spection, had the appearance of a fish-like cut surface. AFigure 2 (A) A uniform population of small round cells with mini
hematoxylin and eosin (magnification, 300). (B) Neoplastic cells w
(C): Expression of Ki67 (40%; En Vision; magnification, 300). (D)
characterized by one fused, one red, and one green signal patter
EWSR1 region have occurred in 22/50 nuclei.pathologic examination found histological evidence of ma-
lignant, small round tumor cells that were not accompanied
by a margin of residual tumor cells (Figure 2). The tumor
cells were immunohistochemically positive for CD99
(Figure 2) and Ki67 (40%; Figure 2), and negative for des-
min, myogenin, synaptophysin, leukocyte common antigen,
S-100 protein, P63 protein, smooth muscle antibody, and
epithelial membrane antigen. To detect chromosome 22q12
translocation, fluorescence in situ hybridization (FISH) was
employed using LSI EWSR1 (22q12) Dual Color, Break Apart
Rearrangement Probe (Vysis; Abbott Molecular, Des Plaines,
IL, USA). Fluorescence was detected using a microscope
with a Y-Fl Epi-Fluorescence Attachment (Nikon, Tokyo,
Japan). Tumor cell nuclei that exhibited a split of signal
pair were scored as positive for translocation and rear-
rangement of chromosome 22q12 (Figure 2).
After surgery, enhanced chest CT and abdominal ultra-
sonography were performed. No evidence of abnormality or
metastasis was detected. However, it was recommended
that the upper left limb be amputated. The patient’s parents
refused, and the infant was transferred to the oncology
department for further treatment 7 days after surgery. Due
to the infant’s young age and the immaturity of her organs,
she received four courses of chemotherapy with cisplatin
(20 mg/m2.day, quaque die  4 days, once every 3 weeks)
and cyclophosphamide (0.2/ m2$d, qd 4 days, once every 3
weeks). However, 3 months later, distant metastasis
involving the lung and liver were detected without local
recurrence. Gradually, the infant became emaciated and
infirm, and eventually she died of dyscrasia.mal cytoplasm and fine granular chromatin nuclei stained with
ith strong expression of CD99 (En Vision; magnification, 300).
Fluorescence in situ hybridization reveals that tumor cells are
n (labeled with lines), and chromosome translocations of the
Table 1 Previous reports of congenital Ewing’s sarcoma and peripheral primitive neuroectodermal tumor of soft tissue in
newborns.
Authors Date Age Sites Treatments Prognosis
Naidu et al8 1989 Birth Forehead Chemotherapy Alive 1 y
Lim et al9 1994 Birth Right lower eyelid Surgery þ chemotherapy Died
Daw et al10 1997 Birth Hand Chemotherapy Died 15 mo
Smith et al11 1998 Birth Skin Surgery þ chemotherapy þ others Died 8 y
Sebire et al12 2002 Birth Back Surgery þ chemotherapy Alive
Sebire et al12 2002 8 d Forearm Radiotherapy Died after 1 wk
Sebire et al12 2002 16 d Neck Chemotherapy Died after 6 mo
El Hayek et al13 2004 Birth Hand Surgery þ chemotherapy Died 2.5 y
Saito et al14 2008 7 d Retroperitoneum Chemo-radiotherapy Survived 2 y and 10 mo
Meazza et al15 2008 Birth Abdomen Chemotherapy Died 25 d
Rosa et al16 2009 Birth Neck None Died 14 h after birth
Krenova et al17 2011 3 wk Retroperitoneum Chemotherapy Died 4 mo
Atla et al18 2011 Birth Chest wall None Died immediately after birth
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EWS and PNET are both small round cell malignancies that
develop in soft tissue and bone. These tumors originate
from the neuroectoderm and are composed of undifferen-
tiated, or poorly differentiated, neuroepithelial cells that
have the capacity to differentiate into neuronal, neuro-
glial, or other mesenchymal cell types.2 PNET and EWS
exhibit differences in their level of cell differentiation.
Accordingly, PNET and EWS are considered two distinct
tumor types. However, immunohistochemistry, electron
microscopy, and genetic pathology have demonstrated that
EWS of bone and extraskeletal tissue, PNET, and Askin’s
tumor are all EWS/PNET tumors.3,4 Furthermore, the
treatment and prognosis for each of these diseases is
essentially identical. In addition, based on the site of
origination, PNETs are classified as central or peripheral.
Four percent of EWS/pPNET cases involve soft tissue
sarcomas. Moreover, although 70e80% of patients experi-
ence tumor onset prior to the age of 20 years, 14% of EWS/
pPNET cases involve children younger than 5 years.5 The
most common symptoms are local pain and a swollen mass,
accompanied by fever or a deteriorating condition.
Elevated leukocyte counts and erythrocyte sedimentation
rate are also frequently observed. Imaging methods typi-
cally show no specific signs, leaving EWS/pPNET to be
diagnosed based on histopathological and immunohisto-
chemical characteristics. In addition, 90% of patients show
reciprocal chromosomal translocations and fused genes
(e.g., the fusion of the EWS gene on chromosome 22q12
with the FLI-1 gene on chromosome 11). The presence of
this chromosome translocation combined with positive im-
munostaining of CD99 represent the sensitive and specific
assays that are currently available for establishing a diag-
nosis of EWS/pPNET.6
At present, the treatment of choice for patients with
EWS/pPNET consists of radical surgical resection followed
by chemoradiotherapy. However, due to the highly malig-
nant and aggressive phenotype of these tumors, approxi-
mately 25% of patients present with distant metastasis at
the time of diagnosis, making it difficult to completely
resect all of the tumor tissue present.7EWS/pPNET tumors are extremely rare in newborns. To
date, only 13 newborns (28 days) with congenital EWS/
pPNET of soft tissue have been reported in the English
literature (Table 1). In all of these reports, the prognosis
was very poor, and most of the infants did not survive more
than 2 years. Consequently, judicious fetal screening is
extremely important. Furthermore, when a fetal soft tissue
mass is revealed by prenatal ultrasound, EWS/pPNET should
be suspected. A mass puncture is necessary and will allow
an immunohistochemistry examination to be performed in
combination with assays to detect chromosome trans-
locations. These results will be useful for a diagnosis of
EWS/pPNET, and they can differentiate it from other con-
ditions. If screening is performed as needed, there should
be a reasonable intervention timely involving radical
resection in the fetal period.
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